10. Trapani, J. A., and M. J. Smyth, “Functional Significance of the Perforin/Granzyme Cell Death Pathway,”
11. Voskoboinik, I., and J. A. Trapani, “Addressing the Mysteries of Perforin Function,”
12. Whiteside, T., and R. B. Herberman, “Characteristics of Natural Killer Cells and Lymphocyte-Activated Killer Cells,”
13. Head, J. F., F. Wang, R. L. Elliott, et al., “Assessment of Immunologic Competence and Host Reactivity Against Tumor Antigens in Breast Cancer Patients: Prognostic Value and Rationale of Immunotherapy Development,”
14. Levy, S. M., R. B. Herberman, M. Lippman, et al., “Immunological and Psychosocial Predictors of Disease Recurrence in Patients with Early-Stage Breast Cancer,”
15. Imai, K., S. Matsuyama, S. Miyake, et al., “Natural Cytotoxic Activity of Peripheral-Blood Lymphocytes and Cancer Incidence: An 11-Year Follow-Up Study of a General Population,”
16. Schantz, S. P., B. W. Brown, E. Lira, et al., “Evidence for the Role of Natural Immunity in the Control of Metastatic Spread of Head and Neck Cancer,”
17. Herberman, R. B., “Immunotherapy,” in Clinical Oncology, ed. R. J. Lenhard, R. Osteen, and T. Gansler (Atlanta, GA: American Cancer Society, 2001), 215-23.
18. MacKie, R. M., R. Reid, and B. Junor, “Fatal Melanoma Transferred in a Donated Kidney 16 Years after Melanoma Surgery,”
19. Cui, Z., “The Winding Road to the Discovery of the SR/CR Mice,”
20. Koebel, C. M., Vermi, W., Swann, J. B., et al., “Adaptive Immunity Maintains Occult Cancer in an Equilibrium State,”
21. Imai, Matsuyama, Miyake, et al., “Natural Cytotoxic Activity of Peripheral-Blood Lymphocytes and Cancer Incidence.”
22. Herberman, “Immunotherapy.”
23. Levy, S. M., R. B. Herberman, A. M. Maluish, et al., “Prognostic Risk Assessment in Primary Breast Cancer by Behavioral and Immunological Parameters,”
24. Lutgendorf, S. K., A. K. Sood, B. Anderson, et al., “Social Support, Psychological Distress, and Natural Killer Cell Activity in Ovarian Cancer,”
25. Schantz, Brown, Lira, et al., “Evidence for the Role of Natural Immunity in the Control of Metastatic Spread of Head and Neck Cancer.”
26. Dvorak, H. F., “Tumors: Wounds That Do Not Heal: Similarities Between Tumor Stroma Generation and Wound Healing,”
27. Balkwill, F., and A. Mantovani, “Inflammation and Cancer: Back to Virchow?”
28. Peek, R. M., Jr., S. Mohla, and R. N. DuBois, “Inflammation in the Genesis and Perpetuation of Cancer: Summary and Recommendations from a National Cancer Institute-Sponsored Meeting,”
29. Huang, M., M. Stolina, S. Sharma, et al., “Non-Small Cell Lung Cancer Cyclooxygenase-2-Dependent Regulation of Cytokine Balance in Lymphocytes and Macrophages: Up-Regulation of Interleukin 10 and Down-Regulation of Interleukin 12 Production,”
30. Mantovani, A., B. Bottazzi, F. Colotta, et al., “The Origin and Function of Tumor-Associated Macrophages,”
31. Baxevanis, C. N., G. J. Reclos, A. D. Gritzapis, et al., “Elevated Prostaglandin E2 Production by Monocytes Is Responsible for the Depressed Levels of Natural Killer and Lymphokine-Activated Killer Cell Function in Patients with Breast Cancer,”
32. Marx, J., “Cancer Research: Inflammation and Cancer: The Link Grows Stronger,”
33. Wallace, J., “Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases—as an Adjunct in Cancer Therapy,”
34. Crumley, A. B. C., D. C. McMillan, M. McKernan, et al., “Evaluation of an Inflammation-Based Prognostic Score in Patients with Inoperable Gastro-oesophageal Cancer,”
